|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
High Dose Chemotherapy with Ifosfamide, Carboplatin, and Etoposide Followed by Autologous Stem Cell Transplantation in Breast Cancer
Soo Mee Bang, Se Hoon Lee, Eun Kyung Cho, Jung Ae Lee, Young Suk Park, Dong Bok Shin, Jae Hoon Lee, Yung Jue Bang, Seonyang Park, Byoung Kook Kim, Noe Kyeong Kim
J Korean Cancer Assoc.
2000;32(6):1059-1066.
Four Cases of Typhlitis, Developed in Neutropenic State and Treated with Medical Conservative Management
Pill Woon Kim, Hyeon Gyoo Ji, Hyun Sik Jeong, Chan Il Moon, Dong Kyeong Yang, Seung Won Lee, Yon Sil Jung, Ji Ho Choi, Gui Hyun Nam, Jae Hoon Lee, Dong Bok Shin
J Korean Cancer Assoc.
1997;29(5):906-913.
Effect of Cytosine Arabinoside and Daunorubicin (AD) Combination Chemotherapy in Acute Myelogenous Leukemia
Yeoung Sook Kang, Hyun Sik Jeong, Tae Seok Kim, Hyun Seon Yun, Deuk Jo Kim, Jeong Ho Yun, Seong Goyng Lee, Hyeon Gyoo Ji, Gui Hyun Ham, Jae Hoon Lee, Dong Bok Shin
J Korean Cancer Assoc.
1997;29(1):160-170.
Phase II trial of recombinant interferon-gamma(LBD-001) in patients with malignancies
Chang In Suh, Won Ki Kang, Heung Tae Kim, Jae Hoon Lee, Dae Seog Heo, Yung Jue Bang, Seonyang Park, Byoung Kook Kim, Noe Kyeong Kim, Young Suk Park, Keun Chil Park, Sung Rok Kim
J Korean Cancer Assoc.
1992;24(4):549-561.
Treatment of intermediate-grade non-Hodgkin's lymphoma with CAMP-MOB combination chemotherapy
Chang In Suh, Heung Tae Kim, Dong Bok Shin, Jae Hoon Lee, Dae Seog Heo, Yung Jue Bang, Seonyang Park, Byoung Kook Kim, Noe Kyeong Kim
J Korean Cancer Assoc.
1992;24(1):102-108.
1
Journal Impact Factor 4.6